CHOROIDEREMIA ASSOCIATED WITH A NOVEL SYNONYMOUS MUTATION IN GENE ENCODING REP-1

Purpose: To report a novel synonymous mutation in CHM and the associated phenotype in an affected man and carrier mother. Methods: Case report. Results: A 34-year-old man with a long history of progressive night blindness and visual field constriction was diagnosed with choroideremia based on ocular examination and multimodal retinal imaging. Extensive chorioretinal degeneration was noted on spectral domain optical coherence tomography and fundus autofluorescence imaging. Candidate CHM gene sequencing revealed a hemizygous c.1359C>T, p.(S453S) variant. This variant was heterozygous in the mother of the proband who exhibited the classic carrier phenotype of choroideremia on fundus autofluorescence imaging. Conclusion: A novel c.1359C>T, p.(S453S) variant in CHM is the first-identified synonymous mutation associated with disease manifestation in an affected man and carrier phenotype in a heterozygous mother.

[1]  Jesse D. Sengillo,et al.  Correction of Monogenic and Common Retinal Disorders with Gene Therapy , 2017, Genes.

[2]  S. Tsang,et al.  PHENOTYPING CHOROIDEREMIA AND ITS CARRIER STATE WITH MULTIMODAL IMAGING TECHNIQUES , 2017, Retinal cases & brief reports.

[3]  K. Xue,et al.  The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype , 2016, Investigative ophthalmology & visual science.

[4]  C. Rivolta,et al.  A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice , 2016, PloS one.

[5]  F. Cremers,et al.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial , 2014, The Lancet.

[6]  A. Levin,et al.  Lyonization in ophthalmology , 2013, Current opinion in ophthalmology.

[7]  L. Vitagliano,et al.  Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with rab geranylgeranyl transferase , 2011, Human mutation.

[8]  J. Hollyfield,et al.  Choroideremia: Analysis of the Retina from a Female Symptomatic Carrier , 2008, Ophthalmic genetics.

[9]  K. McTaggart,et al.  Mutational analysis of patients with the diagnosis of choroideremia , 2002, Human mutation.

[10]  J. Pereira-Leal,et al.  Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease , 2001, FEBS letters.

[11]  A. Milam,et al.  Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia. , 2001, Ophthalmology.

[12]  I. MacDonald,et al.  Histopathology of the retinal pigment epithelium of a female carrier of choroideremia. , 1997, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[13]  A. Chapelle,et al.  Aberrant splicing of the CHM gene is a significant cause of choroideremia , 1992, Nature Genetics.

[14]  J. Parker,et al.  Pathological study in a female carrier of choroideremia. , 1988, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.